Bing Wei
Impact in
-
- Breast Lesions and Carcinomas
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 29
- HER2/EGFR in Cancer Research 9
- Cancer Cells and Metastasis 5
-
- Breast Lesions and Carcinomas 14
- Co-authors
- Hong Bu (28 shared papers)Yun Wu (7 shared papers)Susan C. Abraham (5 shared papers)Zhang Zhang (15 shared papers)Constance T. Albarracin (6 shared papers)Huijiao Chen (11 shared papers)Hongying Zhang (9 shared papers)Zhen Tian (3 shared papers)
- Journals
- Breast Cancer Research and Treatment (4 papers)Human Pathology (3 papers)Journal of Clinical Pathology (3 papers)Clinica Chimica Acta (2 papers)Molecular Oncology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Bing Wei
104 papers receiving 1.8k citations
Bing Wei's Hit Papers
Peers
Comparison fields: 5 of 107
- Pathology and Forensic Medicine 452
- Cancer Research 335
- Oncology 541
- Pulmonary and Respiratory Medicine 374
- Dermatology 95
Countries citing papers authored by Bing Wei
This map shows the geographic impact of Bing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Wei more than expected).
Fields of papers citing papers by Bing Wei
This network shows the impact of papers produced by Bing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Wei. The network helps show where Bing Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 147 | |
| 2 | 2014 | 122 | |
| 3 | 2013 | 115 | |
| 4 | 2014 | 83 | |
| 5 | Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma. | 2005 | 76 |
| 6 | 2013 | 75 | |
| 7 | Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China Hit paper breakdown → | 2024 | 63 |
| 8 | 2008 | 62 | |
| 9 | 2011 | 62 | |
| 10 | 2011 | 47 | |
| 11 | 2012 | 41 | |
| 12 | 2019 | 41 | |
| 13 | 2014 | 37 | |
| 14 | 2013 | 34 | |
| 15 | 2007 | 30 | |
| 16 | 2016 | 27 | |
| 17 | Reproducibility of the Nottingham modification of the Scarff-Bloom-Richardson histological grading system and the complementary value of Ki-67 to this system. | 2010 | 27 |
| 18 | 2009 | 27 | |
| 19 | 2015 | 26 | |
| 20 | 2022 | 26 |
About Bing Wei
Bing Wei is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Rheumatology, having authored 109 papers that have together received 1.9k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (14 papers), Lung Cancer Treatments and Mutations (12 papers), HER2/EGFR in Cancer Research (9 papers), Transplantation: Methods and Outcomes (7 papers), Cancer Cells and Metastasis (5 papers), Soft tissue tumor case studies (5 papers), Cancer Genomics and Diagnostics (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (452 citations), Cancer Research (335 citations), Oncology (541 citations), Pulmonary and Respiratory Medicine (374 citations) and Dermatology (95 citations). Bing Wei has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hong Bu, Yun Wu, Susan C. Abraham, Zhang Zhang, Constance T. Albarracin, Huijiao Chen, Hongying Zhang, Zhen Tian, Jun Wang and David G. Hicks. Their work appears in journals such as Breast Cancer Research and Treatment, Human Pathology, Journal of Clinical Pathology, Clinica Chimica Acta and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.